Matt Bennett News
-
Four Democratic senators who defied President Barack Obama to help defeat gun-safety legislation are facing the wrath of activists who promise to make them pay a political price.
-
Senate hearings, lawsuits and an Internal Revenue Service questionnaire are placing new scrutiny on nonprofit groups that spend millions of dollars on political campaigns without disclosing their donors.
-
Drugmakers may push to boost U.S. government spending on prescription drugs even as the U.S. Congress seeks to reduce health-care spending, according to internal documents from the industry’s top lobbying group.
-
The window for President Barack Obama to accomplish big things may have closed.
-
There was plenty of debate about the new health-care law in the 2010 congressional elections while little, if any, on birth control.
-
Gina Raimondo was running a Rhode Island venture-capital firm in Providence when the mother of two read with alarm that a growing fiscal crisis might force cutbacks in library hours and bus service in 2009.
-
Representative Zack Space , a two- term Democrat running for re-election in Ohio, faces an online campaign urging voters to boycott his candidacy. The anti- incumbent pitch isn’t from Republicans or Tea Party activists.
-
Drugmakers led by Pfizer Inc. agreed to run a “very significant public campaign” bankrolling political support for the 2010 health-care law, including TV ads, while the Obama administration promised to block provisions opposed by drugmakers, documents released by Republicans show.
-
A Republican demand that an increase in the U.S. debt limit be matched by spending reductions may do more than force painful cuts. It could mean another vote on the borrowing cap at the height of the 2012 election campaign.
-
MF Global Holdings Ltd. argued in a December 2010 letter to regulators that futures brokers didn’t need tighter restrictions on how they invest client funds. Ten months later, as MF Global filed for bankruptcy, about $1.6 billion in customer accounts was missing.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page